Aug 12, 2020
Yoga Shown to Improve Anxiety, Study Shows
Jun 18, 2020
Rising Anxiety & Mental Health Issues are a Growing Concern as People Continue to Work From Home
May 18, 2020
VistaGen Submits PH94B Phase 2A Study Protocol for Treatment of Adjustment Disorder with Anxiety Related to the COVID-19 Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
May 06, 2020
Lief Therapeutics Announces Downtime(TM) Digital Anxiety Treatment Now Available Under FDA's COVID-19 Emergency Guidance
Apr 28, 2020
VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19
Feb 10, 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Jan 23, 2020
China Pregabalin Market Analysis and Outlook 2013-2024 - Major Manufacturers' Market Shares, Sales Price, Future Prospects
Dec 05, 2019
Biohaven Announces Issuance of Composition of Matter Patent on Troriluzole by the U.S. Patent and Trademark Office
Nov 26, 2019
MindBeacon Group expands their clinician-guided digital therapy capability to target insomnia
Nov 07, 2019
VistaGen Therapeutics Reports Fiscal 2020 Second Quarter Financial Results and Provides Pipeline Overview
Oct 28, 2019
Biohaven Completes Enrollment In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
Oct 10, 2019
PhRMA Report Shows Nearly 140 Medicines in Development to Treat Mental Illness
Oct 08, 2019
VistaGen Therapeutics Announces Last Patient Completes Dosing in the ELEVATE Phase 2 Clinical Study of AV-101 for Major Depressive Disorder
May 16, 2019
Visiongain Report Claims there is Huge Potential within the $14bn Antidepressant and Anti-Anxiety Drugs Market
Feb 20, 2019
New Research Shows Significant Improvements In Mental Health With The Use Of Online Interventions In A Real-World Setting
Feb 20, 2019
Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
Feb 06, 2019
Patients with depression and anxiety can now start the path to treatment immediately with Bright.md's SmartExam(TM)
Feb 04, 2019
Positive RCT Results Validate GAIA AG's Standing As Leader in Evidence-Based Digital Therapeutics
Aug 16, 2018
Biohaven Reports Positive Results From Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety
May 24, 2018
Commencement of BNC210 Phase 2 Clinical Trial for the Treatment of Agitation